March 13, 2023

(Senior) Technician Quality Control

Pleased to meet you, we are CellPoint, a Galapagos company. We’re a dynamic fast growing Biotech company, in the business of changing lives.
Galapagos’ mission is to make a lasting positive contribution to society through discovery of innovative therapies for diseases with large unmet medical need. Galapagos seeks to develop a robust portfolio of therapies that have the potential to revolutionize existing treatment paradigms. The company’s ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines to improve patients’ lives. Galapagos’ historic focus on developing first-in-class medicines based on the discovery of novel targets in inflammation and fibrosis has led to the successful launch of our first medicine in rheumatoid arthritis in 2020 and in ulcerative colitis in 2021.

Galapagos is now entering an exciting new chapter to expand and diversify its pipeline for the future, starting with oncology, specifically CAR-T cell-therapy, a transformative treatment of different types of cancer. Through the combined acquisitions of CellPoint and AboundBio, we are propelling ourselves into next-generation cell therapies. CellPoint brings a novel, decentralized point-of-care gene therapy manufacturing model which offers efficient, 7-day time to treatment and avoids complex logistics, resulting in potential better patient outcomes and broader access. CellPoint currently has two products in Phase I/II clinical trials. For more information, please visit www.cellpoint.bio.
 CellPoint, a Galapagos company

For the CellPoint/Galapagos organization in Leiden (Netherlands), we are looking for a highly motivated (Senior) Technician Quality Control.

As our (Senior) Technician, you will join the Quality Control team in the Leiden Bio Science Park. You are responsible for routine testing of CellPoint’s product and incoming goods using techniques for both analytical and microbiological testing such as ELISA, PCR and Flow Cytometry. You also support method validation, method transfers, instrument maintenance and troubleshooting as well as taking an active role in implementing and following a GMP way of working.

Responsibilities

  • Test CellPoint’s products for release, characterization and monitoring purposes
  • Test and release of incoming goods
  • Perform method validations and method transfers
  • Provide support for instrument maintenance and troubleshooting
  • Provide support in maintaining an efficient GMP laboratory
  • Take part in laboratory investigations
  • Write procedures and support deviations, change controls and CAPAs

Profile

  • BSc or MSc degree in life sciences, biotechnology, or related discipline with 3 years of experience working in a QC setting in the Biotech and/or Pharmaceutical Industry
  • Experience with flow cytometry, cell-based assays and PCR
  • Knowledge of Microbiological methods is a plus
  • Previous experience in a pharmaceutical/biotech company in a quality control setting
  • Experience working in a GMP environment
  • Strong interpersonal, verbal and written communication skills
  • Ability to be flexible with changing priorities
  • Self-driven and can-do mindset, without compromising quality
  • Fluent in English

Offer

You will be part of a fast growing and amazing company. As ‘make-it-happener’ you will get all the support you need to make your job successful. At Galapagos we aim to recruit the best people, who stand out among their peers, with integrity and excellent interpersonal and organizational skills. Our employees are the strength behind Galapagos, a highly motivated team, eager to maintain Galapagos’ leading position and achieve breakthroughs in pharmaceutical research. Galapagos offers a competitive remuneration package and a dynamic work environment. 

Other information

We are Galapagos: together we can make it happen…!

Marjolein Buyl
Talent Sourcer
Marjolein.Buyl@glpg.com

Did you know? LUMC focus areas are oncology, population health and regenerative medicine